Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Daiichi and Rigel research new cancer strategy

Executive Summary

Daiichi (Japanese pharma with strong cancer franchise) will support the work of Rigel Pharmaceuticals (functional genomics technology for drug discovery) in an emerging area of oncology therapeutics called protein degradation.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Concluded
Deal Type
  • Alliance
    • Co-Promotion
    • Includes Contract
    • R+D and Marketing-Licensing

Related Companies

Advertisement
UsernamePublicRestriction

Register